Matarin Capital Management’s Select Medical SEM Stock Holding History

Matarin Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-443,122	Closed	-$4.12M	–	321
2018 Q1	$4.12M	Buy	443,122 +19,969	+5%	+$190K	0.31%	119
2017 Q4	$4.02M	Sell	423,153 -54,721	-11%	-$523K	0.31%	125
2017 Q3	$4.94M	Buy	477,874 +58,010	+14%	+$536K	0.42%	93
2017 Q2	$3.47M	Sell	419,864 -28,317	-6%	-$213K	0.32%	132
2017 Q1	$3.22M	Buy	448,181 +38,645	+9%	+$280K	0.32%	130
2016 Q4	$2.92M	Sell	409,536 -111,757	-21%	-$778K	0.33%	121
2016 Q3	$3.79M	Buy	521,293 +16,351	+3%	+$104K	0.42%	114
2016 Q2	$2.96M	Buy	+504,942	New	+$3.35M	0.4%	105

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Matarin Capital Management's SEM Position: Q2 2018 in Review

Matarin Capital Management sold out of Select Medical (SEM) in Q2 2018, closing a stake of 443,122 shares — an estimated $4.12M sold.

Matarin Capital Management first reported a position in SEM in Q2 2016 and held it in 8 quarters. The position peaked at $4.94M in Q3 2017. 198 funds tracked by Wall St. Rank hold SEM as of Q2 2018.

Matarin Capital Management reported no remaining Select Medical position as of Q2 2018 after selling out during the quarter.
Matarin Capital Management sold 443,122 Select Medical shares in Q2 2018, an estimated $4.12M.
Matarin Capital Management first reported a position in Select Medical in Q2 2016 and held it in 8 quarters.
Matarin Capital Management's Select Medical position peaked at $4.94M in Q3 2017.
198 funds tracked by Wall St. Rank held Select Medical as of Q2 2018.

Based on Matarin Capital Management's 13F filing for Q2 2018, filed 17 Aug 2018.